Morgan Stanley raises Rollins stock price target to $58 on model update

Morgan Stanley raised its price target on Rollins (ROL) to $58.00 from $53.00, while maintaining an Equalweight rating, citing updated financial models. The firm acknowledged Rollins' strong execution, defensive business model, and proven M&A strategy, but noted the stock's high valuation at 36.3x EV/EBITDA, suggesting more attractive opportunities exist elsewhere in their coverage despite other analysts like Jefferies and Piper Sandler initiating or upgrading with Buy/Overweight ratings following solid Q1 2025 earnings.

Analysis

Analyst sentiment on Rollins, Inc. (ROL) is bifurcated, primarily due to a conflict between its strong fundamentals and elevated valuation. Morgan Stanley raised its price target to $58.00 but maintained an Equalweight rating, flagging the stock's high multiple, which currently stands at 36.3x EV/EBITDA according to InvestingPro data. While the firm deems Rollins' valuation premium over peers as appropriate and acknowledges its strong execution, proven M&A strategy, and defensive business model, it suggests more attractive opportunities exist elsewhere. This cautious stance contrasts sharply with more bullish outlooks from Jefferies, which upgraded the stock to Buy with a $65.00 price target, and Piper Sandler, which initiated coverage with an Overweight rating and a $70.00 target. The company's operational health underpins the positive sentiment, evidenced by in-line Q1 2025 results (EPS $0.22, revenue $823 million), impressive gross margins of 52.69%, and a newly announced quarterly dividend of $0.165 per share. The stock's 19.74% year-to-date return, trading near its 52-week high, reflects investor confidence but also reinforces the valuation concerns highlighted by Morgan Stanley.

Key Decisions for Investors

• Investors should weigh the conflicting analyst views; the bullish cases from Jefferies and Piper Sandler are predicated on high-quality growth, while Morgan Stanley's caution centers on the stock's premium valuation.
• Given the stock trades near its 52-week high at a 36.3x EV/EBITDA multiple, potential investors should assess if the company's defensive characteristics and M&A track record justify paying a premium or if waiting for a better entry point is more prudent.
• Current shareholders may consider holding their positions to benefit from the consistent dividend and the business's resilience in economic slowdowns, while remaining mindful that the high valuation could limit near-term upside potential.